top
Search terms
Results 1 - 6 of 6 - ordered by :
Congress365

The presentation concerned what to do in cases of low thromboembolic risk, and in the presence of a high risk of bleeding in patients with AF. In the first case presentation, Dr. Elaine Hylek from ...

Date : 05/09/2017
Ehjournal

Current Considerations for Novel Oral Anti-Coagulants (NOACs) in Atrial Fibrillation from the European Society of Cardiology Cardiovascular Roundtable The Cardiovascular Round Table (CRT) of the ...

European Heart Journal, Kirchhof, Paulus, Schroeder, Stefan

Date : 14/08/2017
Ehjournal

Current Considerations for Novel Oral Anti-Coagulants (NOACs) in Atrial Fibrillation from the European Society of Cardiology Cardiovascular Roundtable The Cardiovascular Round Table (CRT) of the ...

European Heart Journal, Kirchhof, Paulus, Schroeder, Stefan

Date : 14/08/2017 Item size : 104946 bytes
Ehjournal

The risk of major bleeding with vitamin K antagonists (VKAs) is dependent on the quality of anticoagulation control and estimated to be 1.3/100 patients/year in patients with INR 2.03.0.1,2 Multiple ...

European Heart Journal, Niessner, Alexander, Tamargo, Juan, Morais, João, Koller, Lorenz, Wassmann, Sven, Husted, Steen Elkjær, Torp-Pedersen, Christian, Kjeldsen, Keld, Lewis, Basil S., ...

Date : 07/06/2017 Item size : 436107 bytes
Ehjournal

To address this issue, the Working Group on Cardiovascular Pharmacotherapy and the Working Group on Thrombosis of the European Society of Cardiology provide a position paper entitled Reversal ...

European Heart Journal, Lüscher, Thomas F.

Date : 07/06/2017
ESC365

Regional distribution of low-voltage-substrate in persistent atrial fibrillation - implications for atrial conduction and risk stratification

Date : 19/03/2018